| Dr Anne Marie Breitinger, MD | |
|
1615 Delaware St, Peacehealth Specialty Clinic, Longview, WA 98632-2367 | |
| (360) 414-2730 | |
| (360) 414-2739 |
| Full Name | Dr Anne Marie Breitinger |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 25 Years |
| Location | 1615 Delaware St, Longview, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871772442 | NPI | - | NPPES |
| 286919 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD00041191 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Regional Medical Center | Corvallis, OR | Hospital |
| Samaritan Lebanon Community Hospital | Lebanon, OR | Hospital |
| Samaritan Albany General Hospital | Albany, OR | Hospital |
| Samaritan Pacific Community Hospital | Newport, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Corvallis Gastroenterology Pc | 8123918380 | 12 |
News Archive
Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.
In the first nine months of the financial year (December 2008 - August 2009), Gerresheimer AG achieved sales of EUR 744.3m (prior year EUR 783.4m). Excluding the Technical Plastics business which has been sold, sales totaled EUR 714.9m, a reduction of 1.7% compared with the prior year. The corresponding operating margin (adjusted EBITDA) for the first three quarters continued on a high level at 17.9%.
Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.
Improving survival among dialysis patients may increase treatment costs significantly, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
Intense lobbying by the National Rifle Association has made Senate confirmation of Dr. Vivek Murthy difficult, if not impossible, media outlets report. Murthy has advocated for stricter gun control laws, calling it a public health issue.
› Verified 2 days ago
| Entity Name | Tuality Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275591984 PECOS PAC ID: 3678486107 Enrollment ID: O20040130000359 |
News Archive
Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.
In the first nine months of the financial year (December 2008 - August 2009), Gerresheimer AG achieved sales of EUR 744.3m (prior year EUR 783.4m). Excluding the Technical Plastics business which has been sold, sales totaled EUR 714.9m, a reduction of 1.7% compared with the prior year. The corresponding operating margin (adjusted EBITDA) for the first three quarters continued on a high level at 17.9%.
Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.
Improving survival among dialysis patients may increase treatment costs significantly, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
Intense lobbying by the National Rifle Association has made Senate confirmation of Dr. Vivek Murthy difficult, if not impossible, media outlets report. Murthy has advocated for stricter gun control laws, calling it a public health issue.
› Verified 2 days ago
| Entity Name | Corvallis Gastroenterology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124075627 PECOS PAC ID: 8123918380 Enrollment ID: O20040319000439 |
News Archive
Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.
In the first nine months of the financial year (December 2008 - August 2009), Gerresheimer AG achieved sales of EUR 744.3m (prior year EUR 783.4m). Excluding the Technical Plastics business which has been sold, sales totaled EUR 714.9m, a reduction of 1.7% compared with the prior year. The corresponding operating margin (adjusted EBITDA) for the first three quarters continued on a high level at 17.9%.
Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.
Improving survival among dialysis patients may increase treatment costs significantly, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
Intense lobbying by the National Rifle Association has made Senate confirmation of Dr. Vivek Murthy difficult, if not impossible, media outlets report. Murthy has advocated for stricter gun control laws, calling it a public health issue.
› Verified 2 days ago
| Entity Name | Tuality Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.
In the first nine months of the financial year (December 2008 - August 2009), Gerresheimer AG achieved sales of EUR 744.3m (prior year EUR 783.4m). Excluding the Technical Plastics business which has been sold, sales totaled EUR 714.9m, a reduction of 1.7% compared with the prior year. The corresponding operating margin (adjusted EBITDA) for the first three quarters continued on a high level at 17.9%.
Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.
Improving survival among dialysis patients may increase treatment costs significantly, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
Intense lobbying by the National Rifle Association has made Senate confirmation of Dr. Vivek Murthy difficult, if not impossible, media outlets report. Murthy has advocated for stricter gun control laws, calling it a public health issue.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anne Marie Breitinger, MD Po Box 3002, Peacehealth Specialty Clinic, Longview, WA 98632-0302 Ph: (360) 414-2730 | Dr Anne Marie Breitinger, MD 1615 Delaware St, Peacehealth Specialty Clinic, Longview, WA 98632-2367 Ph: (360) 414-2730 |
News Archive
Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.
In the first nine months of the financial year (December 2008 - August 2009), Gerresheimer AG achieved sales of EUR 744.3m (prior year EUR 783.4m). Excluding the Technical Plastics business which has been sold, sales totaled EUR 714.9m, a reduction of 1.7% compared with the prior year. The corresponding operating margin (adjusted EBITDA) for the first three quarters continued on a high level at 17.9%.
Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.
Improving survival among dialysis patients may increase treatment costs significantly, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
Intense lobbying by the National Rifle Association has made Senate confirmation of Dr. Vivek Murthy difficult, if not impossible, media outlets report. Murthy has advocated for stricter gun control laws, calling it a public health issue.
› Verified 2 days ago
Yoon Hee Amy Chang, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-7800 | |
Alexander Shar, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-7878 Fax: 360-414-7876 | |
Mr. Anawin Sanguankeo, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2730 Fax: 360-414-2739 | |
Lyudmila E Kruzhkov, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-501-3601 | |
Dr. Sahar Taqui, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2730 | |
James J Nakashima, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2700 Fax: 360-414-2714 | |
Gaurav Gandhi, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-501-3601 Fax: 360-414-5768 |